Frontiers in alopecia areata pathobiology research

Alopecia areata.

n engl j med 367;3 nejm.org july 19, 2012 279 methacin should be used in addition to pancre­ atic stents in high­risk patients. However, post hoc analysis of our trial suggests that indometha­ cin may obviate the need for prophylactic pan­ creatic stent placement (unpublished data), and we therefore agree with Baron et al. that com­ parative effectiveness studies of indomethacin and pancreatic ...

Third International Research Workshop on Alopecia Areata.

The Third International Research Workshop on Alopecia Areata was held in Washington DC on November 5, 1998. The conference was organized jointly by the National Alopecia Areata Foundation and the National Institute of Arthritis and Musculoskeletal and Skin Diseases with organizers Vera H. Price, Alan Moshell, Kurt S. Stenn, Madeleine Duvic, Lowell A. Goldsmith, Michael J. Cork, and Rudolf Happl...

Alopecia areata.

Alopecia areata is a frequent cause of hair loss. The origin of disease is not fully understood. However there are indications for a T-cell mediated autoimmune process. Genetic, immunologic and psychologic factors are important for the outbreak of disease. Most patients show localized patches of acute hair loss, where regrowth is observed spontaneously or with simple topical treatment within fe...

Alopecia Areata

Eye involvement in Alopecia Areata

Background: Alopecia areata is a patchy hair loss that may occur in any hair bearing area on the body. There are many reports of ocular abnormalities such as lens and retinal changes in alopecia areata. Objective: To evaluate ocular alterations in alopecia areata with regard to the lens and retina. Patients & Methods: Seventy three patients with alopecia areata including 34 males and 39 f...